Sectors
Health
Headquarters
4550 Montgomery Avenue, Suite 950N, Bethesda, MD, 20814, United States
CEO
Farzad Mostashari
Aledade shares, as of April 21, 2025, are valued at a price per share implying an approximate +22.37% relative to the most recent significant secondary market activity in December 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Aledade's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Aledade.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
Aledade shares, as of April 21, 2025, are valued at a price per share implying an approximate +22.37% relative to the most recent significant secondary market activity in December 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Aledade's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Aledade.
Aledade's mutual fund disclosures indicate a three-month moving average fund price per share of $37.96 as of February 27, 2025, according to PM Insights' market data.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
